Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT02199600 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Medacta International GMK Sphere Post-Marketing Surveillance Study

StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Minor Re-verified, no change to tracked fieldsv7
  2. Notable Primary completion date: Oct 2019 to Oct 2029 Completion date: Apr 2029 to Oct 2029 · Study description expanded, about 72 wordsv6 Show 2 more changesShow less
    • Completion date: Apr 2029 to Oct 2029
    • Study description expanded, about 72 words

    See this version in full on ClinicalTrials.gov ↗

  3. Minor Re-verified, no change to tracked fieldsv5
  4. Minor Trial status: Recruiting to Active, Not Recruiting Primary completion date changed from estimate of Oct 2022 to Oct 2019 · Completion date: Apr 2029 · Site details revised at 4 of 4 sitesv4 Show 3 more changesShow less
    • Primary completion date changed from estimate of Oct 2022 to Oct 2019
    • Completion date: Apr 2029
    • Site details revised at 4 of 4 sites
  5. Minor Re-verified, no change to tracked fieldsv3
  6. Minor Study arms: 0 to 1v2
  7. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a Post-Marketing Surveillance of GMK Sphere knee prosthesis.
Trial Details
NCT Number NCT02199600
Lead Sponsor Medacta International SA
Conditions Arthritis, Traumatic Arthritis, Rheumatoid Arthritis, Poly-arthritis, Avascular Necrosis
Enrollment 500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov